Similarly to CD6-deficient mice [11,12,13], ALCAM-deficient mice were found to develop a reduced T cell response in vivo, as recently demonstrated in mouse models of asthma, atopic dermatitis, and food allergies [10,14,15]. This evidence concerns the gene ALCAM and atopic eczema.